Leidos (LDOS) Falls: Buy Thesis; Backlog Grows Q2.

Leidos (LDOS) Falls: Buy Thesis; Backlog Grows Q2.

Tue, May 26, 2026

Introduction

Leidos (NYSE: LDOS) posted volatile price action last week, trading near 52-week lows even as the company reinforced a sizable backlog and continued to win government and infrastructure work. Investors face a familiar trade-off: near-term earnings pressure from acquisitions and higher capital spending versus multi-year revenue visibility backed by a large funded backlog and an active contract pipeline.

What moved the stock this week

Share-price weakness versus underlying operations

LDOS’s share decline has largely reflected sentiment and index dynamics rather than a sudden deterioration in business fundamentals. The pullback put the stock at lower price levels that several analysts described as a potential buying opportunity. Price targets published by coverage providers remain materially above current levels, implying upside based on existing guidance and backlog conversion.

Concrete operational data supporting the business

Critically, Leidos reported a funded backlog north of $48 billion, with funded backlog growth of roughly 31% year-over-year. The company also disclosed quarterly net bookings in the low billions, a sign that contract wins are continuing to flow in. Management highlighted an expected defense technology pipeline of about $8 billion over the next 12 months, adding to awards already secured in recent quarters.

Strategic moves shaping near-term results

Entrust acquisition and energy pipeline expansion

Leidos’s recent acquisition of Entrust Solutions Group has expanded its addressable opportunity in energy infrastructure by approximately $10 billion. That addition shifts revenue mix and creates cross-selling pathways into utilities and critical infrastructure modernization—areas with multi-year spend horizons.

CapEx and integration weigh on GAAP metrics

The company has increased capital expenditure plans to support growth initiatives and integration activities, with a reported CapEx target near $350 million. While these investments position Leidos to capture future revenue, they also contribute to near-term pressure on GAAP margins and free cash flow until synergies and operational improvements materialize.

Investor implications

Why some see the pullback as opportunity

From an investment perspective, the combination of large funded backlog, steady bookings, and strategic acquisitions presents durable revenue visibility. If backlog converts as expected, the recent price weakness can be framed as a tactical entry point for investors focused on secular demand in defense, intelligence, and critical infrastructure IT services.

Risks that remain

Short-term risks include continued integration costs, elevated CapEx requirements, and possible timing mismatches between award recognition and revenue. These factors can compress near-term GAAP profitability even as non-GAAP metrics and cash generation trend positively over time.

Conclusion

Leidos’s stock reaction this week underscores the disconnect that sometimes occurs between headline price moves and operational momentum. Backlog strength and a visible pipeline provide tangible support for revenue and earnings over the medium term, while acquisition-related spend and higher CapEx explain much of the near-term financial drag. For long-term investors who prioritize contract visibility and government spending tailwinds, LDOS’s recent weakness may represent a reasoned entry point; for shorter-term traders, the cadence of integration milestones and cash-flow conversion will be the metrics to watch.